Y Intercept Hong Kong Ltd Buys Shares of 47,491 Arteris, Inc. (NASDAQ:AIP)

Y Intercept Hong Kong Ltd acquired a new position in shares of Arteris, Inc. (NASDAQ:AIP - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 47,491 shares of the company's stock, valued at approximately $328,000. Y Intercept Hong Kong Ltd owned about 0.11% of Arteris at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Needham Investment Management LLC boosted its stake in shares of Arteris by 0.4% in the fourth quarter. Needham Investment Management LLC now owns 2,745,000 shares of the company's stock valued at $27,972,000 after purchasing an additional 10,000 shares during the period. Samjo Management LLC increased its position in shares of Arteris by 0.9% in the 4th quarter. Samjo Management LLC now owns 1,157,250 shares of the company's stock valued at $11,792,000 after purchasing an additional 10,000 shares during the last quarter. G2 Investment Partners Management LLC purchased a new stake in shares of Arteris in the 4th quarter valued at approximately $2,799,000. Millennium Management LLC increased its position in shares of Arteris by 56.5% in the 4th quarter. Millennium Management LLC now owns 238,309 shares of the company's stock valued at $2,428,000 after purchasing an additional 85,996 shares during the last quarter. Finally, Northern Trust Corp increased its position in shares of Arteris by 6.6% in the 4th quarter. Northern Trust Corp now owns 224,443 shares of the company's stock valued at $2,287,000 after purchasing an additional 13,838 shares during the last quarter. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Arteris news, CFO Nicholas B. Hawkins sold 11,000 shares of the business's stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $7.54, for a total value of $82,940.00. Following the transaction, the chief financial officer directly owned 165,596 shares of the company's stock, valued at approximately $1,248,593.84. The trade was a 6.23% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Saiyed Atiq Raza sold 29,544 shares of the business's stock in a transaction on Tuesday, July 29th. The shares were sold at an average price of $10.07, for a total transaction of $297,508.08. Following the completion of the transaction, the director directly owned 653,118 shares in the company, valued at $6,576,898.26. This represents a 4.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 158,366 shares of company stock valued at $1,492,653 in the last ninety days. 29.10% of the stock is currently owned by company insiders.

Arteris Trading Down 8.2%

Shares of Arteris stock traded down $0.81 during trading on Friday, reaching $9.05. The company's stock had a trading volume of 487,299 shares, compared to its average volume of 410,850. The company has a 50-day moving average price of $8.85 and a two-hundred day moving average price of $8.43. The firm has a market cap of $379.92 million, a PE ratio of -11.04 and a beta of 1.45. Arteris, Inc. has a fifty-two week low of $5.46 and a fifty-two week high of $12.64.

Analysts Set New Price Targets

Separately, Rosenblatt Securities restated a "buy" rating and set a $14.00 price objective on shares of Arteris in a research report on Wednesday, May 21st.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.